Teo P M, Chan A T, Lee W Y, Leung S F, Chan E S, Mok C O
Department of Clinical Oncology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.
Hong Kong Med J. 2000 Mar;6(1):29-36.
To investigate the failure patterns and the prognostic factors following postoperative radiotherapy for salivary gland carcinoma.
Retrospective study.
University teaching hospital, Hong Kong.
Fifty patients who had non-disseminated salivary gland carcinoma and who received primary treatment from 1984 through 1993.
Demographic data, cancer T- and N-stages, histological type, site of origin, completeness of surgery, whether postoperative radiotherapy was given, and the clinical outcome.
Two (4%) patients had been treated with radiotherapy alone, six (12%) had undergone radical resection alone, and 42 (84%) had been radically treated by using both modalities. The 5-year overall survival and relapse-free survival rates were 78.4% and 63.1%, respectively. The free from local failure and free from distant metastasis rates at 5 years were 77.2% and 72.8%, respectively. The N-stage was a significant prognostic factor. The site of the primary tumour, T-stage, completeness of surgery, and use of postoperative radiotherapy were not significant independent prognosticators; however, among the T-stage tumours, the b-substage carcinomas had significantly fewer local failures (P=0.040) and better survival rates (P=0.038) than the a-substage carcinomas. There were seven (14%) locoregional failures without distant metastasis, seven (14%) cases of distant metastasis without locoregional failures, and four (8%) locoregional failures preceding distant metastasis; isolated regional relapse was rare (1/50; 2%). All regional failures (5/50; 10%) occurred ipsilateral to the primary lesion. There were no deaths due to lymphoepithelioma-like carcinoma or acinic cell carcinoma.
The N-stage is the main prognostic factor of overall survival, relapse- and metastasis-free recovery, and success of treatment for salivary gland carcinoma. Optimal locoregional treatment can help reduce distant metastasis, and the maximal use of postoperative radiotherapy may contribute to improved locoregional control. Elective ipsilateral neck radiotherapy is indicated for lymphoepithelioma-like carcinoma.
探讨涎腺癌术后放疗后的失败模式及预后因素。
回顾性研究。
香港大学教学医院。
50例非播散性涎腺癌患者,于1984年至1993年接受了初始治疗。
人口统计学数据、癌症T分期和N分期、组织学类型、原发部位、手术完整性、是否接受术后放疗以及临床结局。
2例(4%)患者仅接受放疗,6例(12%)仅接受根治性切除,42例(84%)接受了两种治疗方式的根治性治疗。5年总生存率和无复发生存率分别为78.4%和63.1%。5年局部无复发生存率和远处无转移生存率分别为77.2%和72.8%。N分期是一个重要的预后因素。原发肿瘤部位、T分期、手术完整性和术后放疗的使用并非显著的独立预后因素;然而,在T分期肿瘤中,b亚期癌的局部复发明显少于a亚期癌(P = 0.040),生存率也更高(P = 0.038)。有7例(14%)局部区域复发无远处转移,7例(14%)远处转移无局部区域复发,4例(8%)远处转移前有局部区域复发;孤立性区域复发罕见(1/50;2%)。所有区域复发(5/50;10%)均发生在原发灶同侧。未发生因淋巴上皮瘤样癌或腺泡细胞癌导致的死亡。
N分期是涎腺癌总生存、无复发和转移康复以及治疗成功的主要预后因素。最佳的局部区域治疗有助于减少远处转移,最大程度地使用术后放疗可能有助于改善局部区域控制。淋巴上皮瘤样癌建议行选择性同侧颈部放疗。